Operating Lease, Right-of-Use Asset of Fulgent Genetics, Inc. from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fulgent Genetics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • Fulgent Genetics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $4,961,000, a 8% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,961,000 -$434,000 -8% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $4,950,000 -$1,020,000 -17% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $4,809,000 -$4,377,000 -48% 30 Jun 2025 10-Q 01 Aug 2025 2025 Q2
Q1 2025 $5,058,000 -$4,167,000 -45% 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $5,395,000 -$5,443,000 -50% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $5,970,000 -$6,436,000 -52% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $9,186,000 -$4,872,000 -35% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $9,225,000 -$4,002,000 -30% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $10,838,000 -$3,946,000 -27% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $12,406,000 -$3,957,000 -24% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $14,058,000 -$3,976,000 -22% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $13,227,000 +$6,563,000 +98% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $14,784,000 +$7,643,000 +107% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $16,363,000 +$8,861,000 +118% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $18,034,000 +$15,858,000 +729% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $6,664,000 +$5,736,000 +618% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $7,141,000 +$6,313,000 +762% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $7,502,000 +$4,822,000 +180% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $2,176,000 -$630,000 -22% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $928,000 -$1,597,000 -63% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $828,000 -$1,805,000 -69% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $2,680,000 -$59,000 -2.2% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $2,806,000 +$50,000 +1.8% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $2,525,000 -$333,000 -12% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $2,633,000 -$367,000 -12% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 $2,739,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $2,756,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $2,858,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $3,000,000 01 Jan 2019 10-K 08 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.